Lynn A Paxton

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. doi request reprint Considerations regarding antiretroviral chemoprophylaxis and heterosexuals in generalized epidemic settings
    Lynn A Paxton
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Georgia, USA
    Curr Opin HIV AIDS 7:557-62. 2012
  2. ncbi request reprint Pre-exposure prophylaxis for HIV infection: what if it works?
    Lynn A Paxton
    Division of HIV AIDS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Lancet 370:89-93. 2007
  3. pmc Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities
    Susan C Kim
    O Neill Institute for National and Global Health Law, Georgetown University, Washington, DC, USA
    J Int AIDS Soc 13:24. 2010
  4. doi request reprint Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana
    Michael C Thigpen
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, USA
    N Engl J Med 367:423-34. 2012
  5. doi request reprint CD4(+) cell count, viral load, and drug resistance patterns among heterosexual breakthrough HIV infections in a study of oral preexposure prophylaxis
    Lovemore I Chirwa
    aCDC BOTUSA, Gaborone, Botswana bDivision of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    AIDS 28:223-6. 2014
  6. doi request reprint Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States
    Lisa A Grohskopf
    Epidemiology Branch, Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    J Acquir Immune Defic Syndr 64:79-86. 2013
  7. ncbi request reprint Postexposure prophylaxis for HIV in children and adolescents after sexual assault: a prospective observational study in an urban medical center
    Lisa A Grohskopf
    Epidemiology Branch, Division of HIV AIDS Prevention, National Center for HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Sex Transm Dis 34:69-70. 2007
  8. pmc Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States
    Scott S Santibanez
    Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop K 39, Atlanta, GA 30333, USA
    J Urban Health 83:86-100. 2006
  9. ncbi request reprint Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services
    Dawn K Smith
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, CDC, Atlanta, Georgia 30333, USA
    MMWR Recomm Rep 54:1-20. 2005

Collaborators

Detail Information

Publications9

  1. doi request reprint Considerations regarding antiretroviral chemoprophylaxis and heterosexuals in generalized epidemic settings
    Lynn A Paxton
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Georgia, USA
    Curr Opin HIV AIDS 7:557-62. 2012
    ..To discuss the factors pertinent to the use of pre-exposure prophylaxis (PrEP) by at-risk heterosexuals in countries with generalized HIV epidemics...
  2. ncbi request reprint Pre-exposure prophylaxis for HIV infection: what if it works?
    Lynn A Paxton
    Division of HIV AIDS Prevention, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Lancet 370:89-93. 2007
  3. pmc Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities
    Susan C Kim
    O Neill Institute for National and Global Health Law, Georgetown University, Washington, DC, USA
    J Int AIDS Soc 13:24. 2010
    ..This paper identifies the key action points that emerged from the Planning for PrEP meeting...
  4. doi request reprint Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana
    Michael C Thigpen
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, USA
    N Engl J Med 367:423-34. 2012
    ..Preexposure prophylaxis with antiretroviral agents has been shown to reduce the transmission of human immunodeficiency virus (HIV) among men who have sex with men; however, the efficacy among heterosexuals is uncertain...
  5. doi request reprint CD4(+) cell count, viral load, and drug resistance patterns among heterosexual breakthrough HIV infections in a study of oral preexposure prophylaxis
    Lovemore I Chirwa
    aCDC BOTUSA, Gaborone, Botswana bDivision of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    AIDS 28:223-6. 2014
    ..Of the four participants who seroconverted on-study while receiving tenofovir/emtricitabine, none became infected as a result of drug-resistant HIV; moreover, no resistance mutations emerged following seroconversion. ..
  6. doi request reprint Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States
    Lisa A Grohskopf
    Epidemiology Branch, Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    J Acquir Immune Defic Syndr 64:79-86. 2013
    ..To evaluate the clinical safety of daily tenofovir disoproxil fumarate (TDF) among HIV-negative men who have sex with men...
  7. ncbi request reprint Postexposure prophylaxis for HIV in children and adolescents after sexual assault: a prospective observational study in an urban medical center
    Lisa A Grohskopf
    Epidemiology Branch, Division of HIV AIDS Prevention, National Center for HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Sex Transm Dis 34:69-70. 2007
  8. pmc Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States
    Scott S Santibanez
    Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop K 39, Atlanta, GA 30333, USA
    J Urban Health 83:86-100. 2006
    ..It is imperative that public health agencies continue to monitor and combat the HIV epidemic among IDUs to ensure that hard-won gains will not be eroded...
  9. ncbi request reprint Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services
    Dawn K Smith
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, CDC, Atlanta, Georgia 30333, USA
    MMWR Recomm Rep 54:1-20. 2005
    ..Risk-reduction counseling and indicated intervention services should be provided to reduce the risk for recurrent exposures...